HOME >> BIOLOGY >> NEWS
EPA Should Redirect Some Research on Toxic Airborne Particles

WASHINGTON -- As the Environmental Protection Agency (EPA) tightens standards for airborne particulates, it should redirect some research and maintain an integrated study program ensuring that the most serious public health risks posed by the particles are addressed, says a new report by a committee of the National Research Council. To that end, EPA should devote more funds to studying the types of particles most likely to be harmful to human health, the ways the particles cause damage, and the levels of exposure people actually receive.

"Recent studies have consistently shown that airborne particles are somehow associated with adverse health effects, especially for people with heart and lung ailments," said committee chair Jonathan Samet, professor and chair, department of epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore. "But as the new standards begin to take effect, further research must be done to determine precisely which particles pose the greatest health risks, and how. Gathering this information should be of the highest priority. The results will greatly increase the likelihood that money spent on regulating and controlling particulates will fully protect public health."

EPA recently set stricter standards for particulate matter -- a broad class of materials that originate from industrial manufacturing processes, forest fires, automobile exhaust, fossil fuel combustion, wind erosion, and a variety of other sources. The standards were changed after several epidemiological studies found associations between exposure to the particles and serious health consequences, including the exacerbation of asthma and other respiratory tract diseases -- which in some cases were leading to premature deaths. The new standards, set last July, for the first time target particulates smaller than 2.5 microns in diameter. When inhaled, these tiny particles are more l
'"/>

Contact: Molly Galvin, Kristen Nye
news@nas.edu
202-334-2138
The National Academies
1-Apr-1998


Page: 1 2 3 4

Related biology news :

1. Should Roundup Ready soybeans be managed differently than conventional soybeans?
2. Should publicly funded research be free and available to the public?
3. Fine Toothed Combs, Not Chemicals, Should Be Used To Treat Head Lice
4. Iron Supplemented Formula Milk Should Be Free For Inner City Children Into Their Second Year Of Life
5. Should Great Apes Be Given Legal Rights?
6. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
7. Adults Need To Increase Intake Of Folate; Some Women Should Take More
8. Drivers Should Pay More Of Environmental Costs, Report Says
9. Lactose-Intolerant People Should Drink More Milk, Expert Says
10. Infants, Toddlers Should Not Restrict Fat Intake, Experts Say
11. Bee Sting Treatment Should Emphasize Speed, Not Method Of Removal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EPA Should Redirect Some Research Toxic Airborne Particles

(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... at the International Society for Cellular Therapy (ISCT) ... tendinosis currently in a Phase 1/2 clinical trial.  ... from 5:30 PM to 7:00 PM local ...
(Date:5/21/2015)... Prussia, PA (PRWEB) May 21, 2015 ... O’Neill has joined the firm as senior statistician and ... 30 years of experience in the management and analysis ... biologics, pharmaceutical and chemical industries. , “We’re delighted to ... longstanding capabilities in data analytics,” said Dr. Philippe Cini, ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has announced ... Insights" report to their offering. Technical ... the Health and Wellness sector and has identified top ... in the year 2015. The research service provides an ... wellness technologies that are anticipated to have the highest ...
(Date:5/20/2015)... DUBLIN , May 19, 2015 Research and ... addition of the "Global Cell Therapy Market Outlook ... Utilization of cell therapy in tissue and regenerative medicine ... are no other options which could help in the ... in this segment but they are unable to form ...
Breaking Biology Technology:RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Top Technologies in the Health and Wellness Industry 2015 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: